Bernard Tardy

7.6k total citations · 3 hit papers
107 papers, 4.5k citations indexed

About

Bernard Tardy is a scholar working on Internal Medicine, Surgery and Hematology. According to data from OpenAlex, Bernard Tardy has authored 107 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Internal Medicine, 36 papers in Surgery and 28 papers in Hematology. Recurrent topics in Bernard Tardy's work include Venous Thromboembolism Diagnosis and Management (44 papers), Heparin-Induced Thrombocytopenia and Thrombosis (20 papers) and Platelet Disorders and Treatments (13 papers). Bernard Tardy is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (44 papers), Heparin-Induced Thrombocytopenia and Thrombosis (20 papers) and Platelet Disorders and Treatments (13 papers). Bernard Tardy collaborates with scholars based in France, United States and Canada. Bernard Tardy's co-authors include Hervé Decousus, Paul Frappé, Sébastien Bruel, M. Detoc, Amandine Gagneux‐Brunon, Élisabeth Botelho-Nevers, Fabrice Zéni, Florence Parent, Philippe Girard and Yves Page and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Bernard Tardy

104 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

1998 1.2k citations Hervé Decousus, Alain Leizorovicz et al. New England Journal of Medicine profile →
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic

2020 456 citations M. Detoc, Sébastien Bruel et al. profile →
Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey

2020 407 citations Amandine Gagneux‐Brunon, M. Detoc et al. Journal of Hospital Infection profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard Tardy France	30	2.2k	1.4k	1.2k	801	721	107	4.5k
Sabine Eichinger Austria	42	5.7k 2.6×	2.6k 1.8×	3.6k 3.1×	157 0.2×	543 0.8×	155	9.4k
Kevin C. Abbott United States	57	173 0.1×	2.4k 1.7×	996 0.8×	48 0.1×	338 0.5×	216	9.4k
Stefano Barco Germany	32	3.0k 1.4×	829 0.6×	1.7k 1.4×	15 0.0×	393 0.5×	190	5.3k
Fiona Newall Australia	27	833 0.4×	594 0.4×	838 0.7×	59 0.1×	278 0.4×	141	2.5k
John T. Philbrick United States	27	747 0.3×	371 0.3×	468 0.4×	78 0.1×	259 0.4×	48	2.3k
Geoffrey C. Nguyen Canada	54	517 0.2×	3.8k 2.7×	244 0.2×	63 0.1×	185 0.3×	243	9.7k
Bosco Paes Canada	40	590 0.3×	1.4k 1.0×	576 0.5×	18 0.0×	303 0.4×	219	6.1k
Babak Sarani United States	33	151 0.1×	1.8k 1.3×	318 0.3×	97 0.1×	358 0.5×	173	3.9k
Peter N. Cox Canada	29	309 0.1×	1.0k 0.7×	445 0.4×	20 0.0×	170 0.2×	74	6.1k
Lisa K. Hicks Canada	26	603 0.3×	251 0.2×	402 0.3×	35 0.0×	180 0.2×	112	2.7k

Countries citing papers authored by Bernard Tardy

Since Specialization

Citations

This map shows the geographic impact of Bernard Tardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Tardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Tardy more than expected).

Fields of papers citing papers by Bernard Tardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Tardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Tardy. The network helps show where Bernard Tardy may publish in the future.

Co-authorship network of co-authors of Bernard Tardy

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Tardy. A scholar is included among the top collaborators of Bernard Tardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Tardy. Bernard Tardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tardy, Brigitte, Hérvè Chambost, Anne Lienhart, et al.. (2024). Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B. Haemophilia. 30(3). 693–701. 1 indexed citations

Bistervels, Ingrid M., Andréa Buchmuller, & Bernard Tardy. (2022). Inferior vena cava filters in pregnancy: Safe or sorry?. Frontiers in Cardiovascular Medicine. 9. 1026002–1026002. 2 indexed citations

Tardy, Brigitte, Michèle Piot, Martine Alhenc‐Gelas, et al.. (2021). Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice. Biomedicines. 9(4). 332–332. 7 indexed citations

Tardy, Brigitte, Pauline Damien, Édouard Ollier, et al.. (2021). PHILEOS ( haemoPHILia and ostEoporOSis ) Study: protocol of a multicentre prospective case–control study. BMJ Open. 11(1). e042283–e042283. 4 indexed citations

Gagneux‐Brunon, Amandine, M. Detoc, Sébastien Bruel, et al.. (2020). Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey. Journal of Hospital Infection. 108. 168–173. 407 indexed citations breakdown →

Robin, Philippe, Pierre‐Yves Le Roux, Benjamin Planquette, et al.. (2015). Limited screening with versus without 18F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial. The Lancet Oncology. 17(2). 193–199. 72 indexed citations

Tardy-Poncet, B., Michèle Piot, Dominique Brunet, et al.. (2012). TFPI resistance related to inherited or acquired protein S deficiency. Thrombosis Research. 130(6). 925–928. 4 indexed citations

Bidet, Audrey, Dominique Desprez, Emmanuel de Maistre, et al.. (2010). Clinical characteristics and laboratory testing of patients with suspected HIT: A survey on current practice in 11 university hospitals in France. Thrombosis Research. 125(6). e294–e299. 6 indexed citations

Sanchez, Olivier, Ludovic Trinquart, Vincent Caille, et al.. (2009). Prognostic Factors for Pulmonary Embolism: The PREP Study, A Prospective Multicenter Cohort Study. American Journal of Respiratory and Critical Care Medicine. 181(2). 168–173. 166 indexed citations

10.

Elalamy, Ismaı̈l, B. Tardy-Poncet, Emmanuel de Maistre, et al.. (2009). Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia. Thrombosis Research. 124(5). 554–559. 24 indexed citations

11.

Tardy, Bernard, C. Venet, Fabrice Zéni, et al.. (2002). Death of terminally ill patients on a stretcher in the emergency department: a French speciality?. Intensive Care Medicine. 28(11). 1625–1628. 42 indexed citations

12.

Girard, Philippe, M. Décousus, Silvy Laporte, et al.. (2001). Diagnosis of Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis. American Journal of Respiratory and Critical Care Medicine. 164(6). 1033–1037. 40 indexed citations

13.

Elalamy, Ismaı̈l, et al.. (1999). [Diagnosis and development of heparin-induced thrombocytopenia. Biological and clinical aspects].. PubMed. 16(5 Pt 2). 961–74. 5 indexed citations

14.

Tardy-Poncet, B., et al.. (1998). Fatal Danaparoid-sodium Induced Thrombocytopenia and Arterial Thromboses. Thrombosis and Haemostasis. 80(9). 530–530. 11 indexed citations

15.

Mismetti, Patrick, J. Reynaud, S Laporte‐Simitsidis, et al.. (1998). Pharmacokinetic and pharmacodynamic variations of acenocoumarol orally administrated either once or twice daily in patients with deep venous thrombosis. Fundamental and Clinical Pharmacology. 12(6). 631–635. 5 indexed citations

16.

Decousus, Hervé, Alain Leizorovicz, Florence Parent, et al.. (1998). A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 338(7). 409–416. 1166 indexed citations breakdown →

17.

Amiral, Jean, J C Lormeau, Anne Marfaing‐Koka, et al.. (1997). Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagulation & Fibrinolysis. 8(2). 114–117. 92 indexed citations

18.

Tardy-Poncet, B., J. Reynaud, Bernard Tardy, et al.. (1996). [Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].. PubMed. 25(16). 751–5. 3 indexed citations

19.

Page, Yves, et al.. (1990). Cathétérisme veineux et anomalies congénitales de la veine cave supérieure. Annales Françaises d Anesthésie et de Réanimation. 9(5). 450–455. 11 indexed citations

20.

Page, Yves, et al.. (1990). Disseminated Intravascular Coagulation in Fusobacterium necrophorum Septicemia. Scandinavian Journal of Infectious Diseases. 22(6). 743–747. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact